Health

Menarini Group and Radius Health, Inc. announce publication of elacestrant pivotal Phase 3 EMERALD clinical trial data in the Journal of Clinical Oncology

Emerald study met both its primary end points of Progression-free survival (PFS) in overall population and in ESR1 mutated patients PFS rate at 12 months with elacestrant was 22.32% vs. 9.42% with SOC in the overall population, and 26.76% vs. 8.19% in the ESR1 mutation population Data demonstrated elacestrant significantly reduced the risk of disease progression or […]

thaipr.net

23 พ.ค. 65

Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO® (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma

— European Commission Decision Anticipated within Approximately 60 Days — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group (“Menarini”), a privately-held, leading international pharmaceutical company, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has…

thaipr.net

23 พ.ค. 65

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center to host international conference on complex cardiac arrhythmias

EPLive 2022 is a two-day conference that draws the world’s top cardiac electrophysiology experts On June 2 and 3, 2022, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center will host its sixth international symposium on complex arrhythmias, EPLive 2022.  EPLive is an intensive, two-day educational meeting for practicing clinical cardiac electrophysiologists, electrophysiologist […]

thaipr.net

23 พ.ค. 65

CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays

This acquisition solidifies CellCarta’s leadership position in proteomics services with a unique combination of validated set of reagents and multiplex assays, including pathway specific off-the-shelf panels, allowing for clinical protein quantification covering a comprehensive range of immuno-oncology targets.      CellCarta, a leading global provider of precision medicine laboratory services, announced today the acquisition of the…

thaipr.net

20 พ.ค. 65

ECCMID 2022: Copan unveils its WISE approach to sample management

Copan took the chance of the first in-person ECCMID of the last two years to give a name to its holistic approach to preanalytics. From sample collection to image analysis and data interpretation, meet Copan’s WISE approach, which brings any sample to improved diagnostics. Preanalytics – sample collection, processing, and other activities that make samples analyzable by […]

thaipr.net

12 พ.ค. 65

OMRON Healthcare Unveils Long-term Corporate Vision, “Going for ZERO, Preventive Care for Health of Society”

– Aiming to Realize 3 Zeros: “Zero Cerebrovascular and Cardiovascular Events,” “Zero Aggravation of Respiratory Diseases” and “Zero Restrictions on Daily Activities Due to Chronic Pain” – In March 2022, OMRON Group announced a new long-term vision, “Shaping the Future 2030” (hereafter referred to as SF2030). In its commitment to achieving this vision for the […]

thaipr.net

10 พ.ค. 65
1 … 73 74 75 76 77 … 130

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.